CHIP is a novel tumor suppressor in pancreatic cancer and inhibits tumor growth through targeting EGFR
PDF | HTML | How to cite
Metrics: PDF 2597 views | HTML 2731 views | ?
Tianxiao Wang1, Jingxuan Yang2, Jianwei Xu1, Jian Li1, Zhe Cao1, Li Zhou1, Lei You1, Hong Shu1, Zhaohui Lu3, Huihua Li4, Min Li2, Taiping Zhang1, and Yupei Zhao1
1 Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
2 The Vivian L. Smith Department of Neurosurgery, the University of Texas Medical School at Houston, Houston, Texas, USA
3 Department of Pathology and Pathophysiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
4 Department of Pathology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China
Min Li, email:
Taiping Zhang, email:
Yupei Zhao, email:
Keywords: CHIP, EGFR, pancreatic cancer, ubiquitination
Received: February 25, 2014 Accepted: April 06, 2014 Published: April 08, 2014
Carboxyl terminus of heat shock protein 70-interacting protein (CHIP) is an E3 ubiquitin ligase that is involved in protein quality control and mediates several tumor-related proteins in many cancers, but the function of CHIP in pancreatic cancer is not known. Here we show that CHIP interacts and ubiquitinates epidermal growth factor receptor (EGFR) for proteasome-mediated degradation in pancreatic cancer cells, thereby inhibiting the activation of EGFR downstream pathways. CHIP suppressed cell proliferation, anchor-independent growth, invasion and migration, as well as enhanced apoptosis induced by erlotinib in vitro and in vivo. The expression of CHIP was decreased in pancreatic cancer tissues or sera. Low CHIP expression in tumor tissues was correlated with tumor differentiation and shorter overall survival. These observations indicate that CHIP serves as a novel tumor suppressor by down-regulating EGFR pathway in pancreatic cancer cells, decreased expression of CHIP was associated with poor prognosis in pancreatic cancer.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.